Skip to main content
Log in

Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Backgroud

Dedifferentiated chondrosarcoma represents a special form of the chondrosarcoma characterized by the presence of well-differentiated cartilaginous component in juxtaposition with the malignant mesenchymal tumor of high-malignancy grade.

Methods

The study was performed on 25 tissue samples obtained by biopsy of the primary malignant bone tumors.

Results

Out of the total of 25 patients, 13 were males and 12 were females. Their average age was 59.9 years (39–75). Radiological examination verified the presence of the pathological fractures in 14 patients. The skeletal distribution clearly indicates that the femur is the most frequent site of affection (in 15 patients—60%). Morphological analysis verified the presence of “precursor cartilaginous lesion” or low-grade cartilaginous component in all cases. Classification of the high-grade components was based on the immunohistochemical analyses, which evidenced MFH in 18 cases, osteosarcoma in 4, while fibrosarcoma was evidenced in 2 and rhabdomyosarcoma in 1 case. In 20 patients, out of whom 14 had existing fractures, amputation was indicated. In five patients (fracture-free), resection limb-salvage surgical intervention was performed.

Conclusion

The lethal outcome ensues within less than 2 years in all patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Chart 1
Fig. 1
Chart 2
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Aigner T (2002) Towards a new understanding and classification of chondrogenic neoplasias of the skeleton—biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 441(3):219–230

    Article  PubMed  CAS  Google Scholar 

  • Bovée JV, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC (2005) Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 6(8):599–607

    Article  PubMed  CAS  Google Scholar 

  • Bruns J, Fiedler W (2005) Dedifferentiated chondrosarcoma—a fatal disease. J Cancer Res Clin Oncol 131(6):333–339

    Article  PubMed  CAS  Google Scholar 

  • Casorzo L, Chiecchio L (2003) Cytogenetic findings in a case of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet 144(1):61–64

    Article  PubMed  CAS  Google Scholar 

  • Dahlin DC, Unni KK (1986) Bone tumors: general aspects and data on 8542 cases, 4th edn. Springfield, Illinois, pp 227–268

    Google Scholar 

  • Dickey ID, Rose PS (2004) Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am 86:2412–2418

    PubMed  Google Scholar 

  • Estrada EG, Ayala AG, Lewis V, Czerniak B, Valerie L (2002) Dedifferentiated chondrosarcoma with a noncartilaginous component mimicking a conventional giant cell tumor of bone. Ann Diagn Pathol 6(3):159–163

    Article  PubMed  Google Scholar 

  • Kinkor Z, Lunácková I (2003) Dedifferentiated chondrosarcoma of bone—report of 5 cases and literature review with emphasis on histogenesis. Cesk Patol 39(2):59–63

    PubMed  CAS  Google Scholar 

  • Pring ME, Weber KL (2001) Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am 83-A(11):1630–1642

    PubMed  CAS  Google Scholar 

  • Rinaggio J, Duffey D, Mc Guff HS (2004) Dedifferentiated chondrosarcoma of the larynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(3):369–375

    Article  PubMed  Google Scholar 

  • Röpke M, Boltze C, Neumann HW, Roessner A, Schneider-Stock R (2003) Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma. Pathol Res Pract 199(6):437–444

    Article  PubMed  Google Scholar 

  • Rzeszutko W, Dziegiel P (2003) The expression of selected immunocytochemical diagnostic markers in the case of chondrosarcoma with a mesenchymal component. Folia Morphol (Warsz) 62(4):513–515

    Google Scholar 

  • Saifuddin A, Mann S, Mahroof S, Pringle J, Briggs T, Cannon S (2004) Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy. Clin Radiol 59(3):268–272

    Article  PubMed  CAS  Google Scholar 

  • Sakamoto A, Oda Y, Adachi T, Oshiro Y, Tamiya S, Tanaka K, Matsuda S, Iwamoto Y, Tsuneyoshi M (2001) H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis. Mod Pathol 14(4):343–349

    Article  PubMed  CAS  Google Scholar 

  • Staals EL, Bacchini P, Bertoni F (2006) Dedifferentiated central chondrosarcoma. Cancer 106(12):2682–2691

    Article  PubMed  Google Scholar 

  • Wick MR, Siegal GP (1987) Dedifferentiated chondrosarcoma of bone. An immunohistochemical and lectin-histochemical study. Virchows Arch 411:23–32

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Goran Tulić.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sopta, J., Đorđević, A., Tulić, G. et al. Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases. J Cancer Res Clin Oncol 134, 147–152 (2008). https://doi.org/10.1007/s00432-007-0262-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-007-0262-5

Keywords

Navigation